The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3

Stefano Sechi; Anna Frappaolo; Giorgio Belloni; Gianni Colotti; Maria Grazia Giansanti

doi:10.18632/oncotarget.3051

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3

Stefano Sechi _, Anna Frappaolo, Giorgio Belloni, Gianni Colotti and Maria Grazia Giansanti

PDF | HTML | How to cite

Oncotarget. 2015; 6:3493-3506. https://doi.org/10.18632/oncotarget.3051

Metrics: PDF 3102 views | HTML 4014 views | ?

Abstract

Stefano Sechi1,*, Anna Frappaolo1,*, Giorgio Belloni2, Gianni Colotti3, Maria Grazia Giansanti1

1Istituto di Biologia e Patologia Molecolari del CNR, Dipartimento di Biologia e Biotecnologie, Sapienza Università di Roma, 00185 Roma, Italy

2Dipartimento di Biologia e Biotecnologie, Sapienza Università di Roma, 00185 Roma, Italy

3Istituto di Biologia e Patologia Molecolari del CNR, Dipartimento di Scienze Biochimiche, Sapienza Università di Roma, 00185 Roma, Italy

* These authors have contributed equally to this work

Correspondence to:

Maria Grazia Giansanti, e-mail: [email protected]

Keywords: GOLPH3, cancer, Golgi

Received: November 06, 2014 Accepted: January 07, 2015 Published: January 23, 2015

ABSTRACT

The highly conserved Golgi phosphoprotein 3 (GOLPH3) protein, a component of Trans-Golgi Network (TGN), has been defined as a “first-in-class Golgi oncoprotein” and characterized as a Phosphatidylinositol 4-phosphate [PI(4)P] effector at the Golgi. GOLPH3 is commonly amplified in several solid tumors. Furthermore this protein has been associated with poor prognosis in many cancers. Highly conserved from yeast to humans, GOLPH3 provides an essential function in vesicle trafficking and Golgi structure. Recent data have also implicated this oncoprotein in regulation of cytokinesis, modulation of mitochondrial mass and cellular response to DNA damage. A minute dissection of the molecular pathways that require GOLPH3 protein will be helpful to develop new therapeutic cancer strategies.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3051

Publication Alerts

Post-Publication Promotion

Reviews:

The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3

Abstract